Literature DB >> 8778293

Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells.

A R McQuiston1, J J Petrozzino, J A Connor, W F Colmers.   

Abstract

Neuropeptide Y (NPY) is far more abundant in the dentate gyrus than elsewhere in the hippocampal formation, but it does not alter the synaptic excitation of dentate granule cells (DGCs) as it does for pyramidal cells in areas CA1 and CA3. NPY inhibited depolarization-induced increases in intracellular Ca2+ concentrations ([Ca2+]i) in DGCs in hippocampal slices, without altering the resting [Ca2+]i. NPY inhibited Ca2+ currents (ICa) via a Y1 receptor in 84% of acutely isolated DGCs and via a Y2 receptor in 31% of the NPY-responsive cells tested. ICa inhibition was completely occluded by omega-conotoxin-GVIA but not by nimodipine. The inhibition of ICa was accompanied by a change in the time course of ICa activation in only 27% of NPY-responsive cells. Only 23% of DGCs responded to NPY when Ba2+ was substituted for extracellular Ca2+ and when [Ca2+]i was strongly buffered. Therefore, NPY inhibits an N-type ICa in DGCs, mainly via Y1 receptors. Furthermore, it seems that more than one mechanism, one of which may be sensitive to [Ca2+]i, may couple NPY receptors to the Ca2+ channels in DGCs. Because the release of dynorphin from DGCs depends in part on N-type currents, NPY receptors are poised to regulate the release of opioid peptides from DGC somata and dendrites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778293      PMCID: PMC6578543     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  14 in total

1.  Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells.

Authors:  Trevor J Hamilton; B Matthew Wheatley; D Barry Sinclair; Madeline Bachmann; Matthew E Larkum; William F Colmers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 3.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

4.  Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.

Authors:  G Chen; A N van den Pol
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

5.  Molecular alterations in areas generating fast ripples in an animal model of temporal lobe epilepsy.

Authors:  Kellen D Winden; Anatol Bragin; Jerome Engel; Dan H Geschwind
Journal:  Neurobiol Dis       Date:  2015-03-25       Impact factor: 5.996

6.  Role of N-type calcium channels in autonomic neurotransmission in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

7.  Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors.

Authors:  H Rhim; G A Kinney; P J Emmerson; R J Miller
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

8.  Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.

Authors:  K Obrietan; A N van den Pol
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

9.  Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.

Authors:  Ngoc Khoi Nguyen; Simone B Sartori; Herbert Herzog; Ramon Tasan; Günther Sperk; Nicolas Singewald
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

10.  Upregulation of gene expression in reward-modulatory striatal opioid systems by sleep loss.

Authors:  Brian A Baldo; Erin C Hanlon; William Obermeyer; Quentin Bremer; Elliott Paletz; Ruth M Benca
Journal:  Neuropsychopharmacology       Date:  2013-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.